Nationwide Laboratory Adherence to Myocardial Perfusion Imaging Radiation Dose Reduction Practices A Report From the Intersocietal Accreditation Commission Data Repository by Jerome, Scott D. et al.
J A C C : C A R D I O V A S C U L A R I M A G I N G VO L . 8 , N O . 1 0 , 2 0 1 5
ª 2 0 1 5 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 5 . 0 7 . 0 0 8Nationwide Laboratory Adherence to
Myocardial Perfusion Imaging
Radiation Dose Reduction Practices
A Report From the Intersocietal Accreditation Commission
Data RepositoryScott D. Jerome, DO,* Peter L. Tilkemeier, MD,y Mary B. Farrell, MS,z Leslee J. Shaw, PHDxABSTRACTFro
Me
an
fro
ne
Ms
rel
MaOBJECTIVES This study sought to examine current laboratory practices for radiation effective doses for myocardial
perfusion imaging (MPI) and laboratory adherence to guideline-directed radiation reduction practices.
BACKGROUND A recent focus on radiation dose reduction for cardiovascular imaging has led to several published
guidelines and consensus statements detailing performance metrics for laboratory practices. We sought to examine
laboratory adherence to optimized radiation dose protocol recommendations among 5,216 submitted cases from 1,074
MPI laboratories evaluated for Intersocietal Accreditation Commission accreditation.
METHODS Eligible imaging centers included MPI laboratories enrolled in the Intersocietal Accreditation Commission
data repository of accreditation applications from 2012 to 2013. Accreditation requires submission of 3 to 5 cases for
evaluation of a range of representative cases. Based on standard dosimetry for rest and stress MPI, an effective dose
(in millisieverts) was calculated. Model simulations were performed to estimate guideline-directed effective doses.
RESULTS The average effective dose was 14.9  5.8 mSv (range 1.4 to 42.4 mSv). A 1-day technetium Tc 99m protocol
was used in 82.9% of cases, whereas a 2-day technetium Tc 99m and dual isotope protocol was used in 7.5% of sub-
mitted cases. Only 1.5% of participating imaging centers met current guidelines for an average laboratory radiation
exposure #9 mSv, whereas 10.1% of patient effective doses were >20.0 mSv. A model simulation replacing the radiation
exposure of dual isotope MPI with that of a 1-day technetium Tc 99m protocol reduced the proportion of patients
receiving an effective dose >20 mSv to only 2.7% of cases (p < 0.0001).
CONCLUSIONS Mandatory laboratory accreditation for MPI allows for examination of current radiation dosimetry
practices. Current guidelines for reduced patient-speciﬁc radiation exposure are rarely implemented, with few labora-
tories meeting recommendations of #9 mSv for 50% of patients. Increased educational efforts and the development of
performance measures for laboratory accreditation may be required to meet current radiation dose-reduction standards.
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AB BR E V I A T I O N S
AND ACRONYM S
ASNC = American Society of
Nuclear Cardiology
IAC = Intersocietal
Accreditation Commission
MPI = myocardial perfusion
imaging
Tc99m = technetium Tc 99m
Tl201 = thallium Tl 201
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1171included a combination of radiation reduction mea-
sures that, if implemented correctly, would result in
quality imaging at the lowest possible radiation dose
(7). Current guidance documents recommend dose-
reduction strategies whereby 50% or more of patients
undergoing single photon emission computed tomog-
raphy myocardial perfusion imaging (MPI) receive a
total effective dose #9 mSv (7). Moreover, a recent
symposium sponsored by the National Institutes of
Health’s National Heart, Lung, and Blood Institute
andNational Cancer Institute proposed that cardiovas-
cular diagnostic procedures with effective doses >20
mSv be rarely employed due to the potential projected
cancer risk and that this threshold should be consid-
ered for laboratory tracking as a performance measure
(5,8).SEE PAGE 1177Current evidence is lacking as to nationwide labo-
ratory practices of radiation dosing patterns, partic-
ularly for MPI due to its high rate of utilization (9).
Recent survey ﬁndings representing only 20% of
ASNC member laboratories revealed unnecessary and
high radiation dose practices with minimal attention
to dose (4). The Intersocietal Accreditation Commis-
sion (IAC) data repository provides a unique oppor-
tunity to evaluate current clinical practice and
radiation dosing patterns from a large nationwide
cohort of laboratories and patients. The aim of this
analysis was to examine current laboratory practice
for radiation effective doses for MPI and laboratory
adherence to guideline-directed radiation reduction
practices (5,7,8).
METHODS
The IAC data repository enrolls prospective submis-
sion of 3 to 5 patient MPI cases as part of laboratory
accreditation requirements. Accreditation require-
ments include submission of 5 MPI cases for nuclear
cardiology and 3 cases for general nuclear medicine
accreditation. Of the submitted cases, only 1 may be
normal with the remaining cases demonstrating an
abnormality. Speciﬁc cases included case 1—normal,
case 2—ischemia, case 3—myocardial infarction, case
4— left ventricular wall motion abnormality, and case
5— an additional abnormality. A total of 1,074 labora-
tories submitted applications for accreditation during
2012 and 2013. This time frame was selected to reﬂect a
stable period of isotope production and availability in
the United States, without restrictions and potential
need for use of higher radiation dose protocols.
LABORATORY CHARACTERISTICS. Laboratory char-
acteristics including state, U.S. region (e.g., south,northeast, west), laboratory type (i.e., hospi-
tal vs. private practice), annual volume of
MPI studies, number of physicians in the
practice, number of physicians certiﬁed by
the Certiﬁcation Board of Nuclear Cardiology,
number of technologists, and number of lo-
cations providing MPI services were also
documented.
CALCULATION OF RADIATION DOSIMETRY.
For each case, a laboratory must submit a ﬁnal
report from which we extracted the amount of
radioactivity injected at rest and stress in millicuries
per patient. We also identiﬁed the standardized MPI
protocol used (technetiumTc 99m [Tc99m] 1-day, Tc99m
2-day, thallium Tl 201 [Tl201]/Tc99m dual isotope, Tl201
or Tc99m stress-only) (10). The effective radiation
exposure per patient was estimated by converting
0.3 mSv/mCi for Tc99m (both Tc99m sestamibi and
Tc99m tetrofosmin were treated similarly) (7) and
6.3 mSv/mCi for Tl201 (11,12). The administered dose
was converted to an effective dose (in millisieverts)
based on ASNC guidance documents (7).
Comparisons were made between the average
effective dose per protocol and the guideline average
recommended dose by protocol: Tc99m 1-day (370
MBq [10 mCi] low dose/1,110 MBq [30 mCi] high dose);
Tc99m 2-day (1,110 MBq [30 mCi] day 1/1,110 MBq [30
mCi] day 2); dual isotope (122 MBq [3.3 mCi] Tl201 rest
dose/1,110 MBq [30 mCi] Tc99m stress dose); and Tl201
(122 MBq [3.3 mCi] stress dose/56 MBq [1.5 mCi] rest
reinjection dose).
STATISTICAL ANALYSIS. The IAC data repository
was locked in 2014 following thorough cleaning and
independent examination of implausible data ranges/
outliers. Initial data analysis included descriptive
statistics evaluating percentages for categorical vari-
ables or mean  SD for continuous variables. Com-
parisons of categorical variables were calculated
using chi-square statistics and Student t tests for
comparisons of continuous measures. Across labora-
tory volume, effective doses, and other continuous
measures, we categorized these variables using me-
dian and interquartile range values.
Comparisonsweremade between the years 2012 and
2013 for alterations in protocol usage, average effective
doses, percentage of cases#9mSv (7) and>20mSv (5).
As well, the frequency of use of the dual isotope pro-
tocol was evaluated, as this is the highest effective
radiation exposure used for MPI. Correlation of the
average observed exposure for each protocol to the
average guideline-directed dosing recommendation
from ASNC was performed by Spearman rho correla-
tion. A model simulation was devised examining
alterations in mean effective dose per laboratory
TABLE 1 Laboratory Characteristics (N ¼ 1,074) From the
IAC Data Repository
Region
Northeast 318 (29.6)
Midwest 165 (15.4)
South 473 (44.0)
West 118 (11.0)
Laboratory type
Private practice 929 (86.5)
Hospital 145 (13.5)
Annual MPI volume 1,000 (566–1,753)
Number of physicians 3 (1–5)
Number of CBNC-certiﬁed physicians 1 (0–2)
Number of technologists 1 (1–3)
Number of sites 1 (1–1)
Values are n (%) or median (IQR).
CBNC ¼ Certiﬁcation Board of Nuclear Cardiology; IAC ¼ Intersocietal Accredi-
tation Commission; MPI ¼ myocardial perfusion imaging.
TABLE 2 Protocol U
Tc99m
1-Day
n (%) 4,324 (82
Mean 12.9
SD 1.8
Minimum 3.6
Maximum 20.3
Tc99m ¼ technetium Tc 99
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1172following elimination of dual isotope imaging and
replacement with a lower effective dose protocol per
ASNC guidelines (13). The results were modeled by
replacing the administered doses of each dual isotope
MPI with the average guideline recommended doses
for a 1-day Tc99m protocol. Statistical difference was
determined using the McNemar test. A p value
<0.05 was chosen to reﬂect statistical signiﬁcance for
all analyses. Statistical analysis was performed using
IBM SPSS version 22.0 (IBM Corporation, Armonk,
New York).
RESULTS
LABORATORY CHARACTERISTICS. The majority of
laboratories were from the southern states, with 30%
located in the northeastern part of the United States
(Table 1). Submitting laboratories were largely deﬁned
as private practice. The median of the annual volume
of rest/stress MPI cases was 1,000 (interquartile range:
566 to 1,753). Submitting laboratories represented a
median of 3 nuclear cardiologists and a median oftilization and Radiation Effective Dose (in mSv)
Tc99m
2-Day
Tl201/Tc99m
Dual Isotope Tl201
Tc99m
Stress-Only Overall
.9) 390 (7.5) 393 (7.5) 86 (1.6) 23 (0.4) 5,216
17.9 32.8 23.9 7.5 14.9
2.9 3.5 3.0 2.5 5.8
5.6 22.1 13.9 1.4 1.4
28.4 42.4 33.4 10.7 42.4
m; Tl201 ¼ thallium Tl 201.1 Certiﬁcation Board of Nuclear Cardiology–certiﬁed
physician per laboratory. The submitting laboratory
had amedian of 1 technologist and amedian of 1.0 sites
for MPI testing.
LABORATORY EFFECTIVE DOSESACROSS LABORATORIES
AND PATIENT CASES. The IAC data repository in-
cluded 5,216 reports from 1,074 laboratories applying
for accreditation with a total of 10,405 rest and
stress administered radiopharmaceutical doses for
MPI. The calculated average effective dose per
patient was 14.9  5.8 mSv with a range of 1.4 to 42.4
mSv.
The Tc99m 1-day protocol was the most frequent
protocol (82.9% of cases), followed by the Tc99m 2-day
protocol and the rest Tl201/stress Tc99m dual isotope
protocols, both at 7.5% (Table 2). Based on the pro-
tocol used, marked variation in radiation effective
dose was observed. The mean effective dose was
12.9 mSv for the Tc99m MPI protocol and increased to
an average of 17.9 mSv for the 2-day Tc99m MPI pro-
tocol. For the 2-day protocol, no signiﬁcant difference
was seen between the effective dose on day 1 versus
day 2: 8.8 mSv and 8.9 mSv (p ¼ 0.251). Higher
average effective doses were observed for Tl201 at
23.9 mSv. The highest average effective dose protocol
was for rest Tl201/stress Tc99m dual isotope protocol at
32.8 mSv. Importantly, the average effective dose was
only 7.5 mSv for a Tc99m stress-only protocol. The
lowest effective dose, 1.4 mSv, was from a stress-only
MPI performed on a cadmium zinc telluride multi-
detector gamma camera.
ADHERENCE TO RADIATION DOSE-REDUCTION
GUIDELINES. A cumulative plot of MPI effective
doses is reported in Figure 1. Only 1.5% of laboratories
reported a median effective dose for rest/stress MPI
of #9 mSv. In total, cases with effective doses #9 mSv
were submitted from only 44 laboratories. Nearly
86% of submitted cases had an effective dose of 10.1
to 20 mSv. By comparison, nearly 1 in 10 laboratories
had a median reported rest/stress MPI effective dose
of >20 mSv. Of those cases, 74.4% resulted from a
dual isotope protocol, 13.8% were from a Tl201 pro-
tocol, and 11.6% were from the Tc99m 2-day protocol.
Of the submitted cases meeting low and high
effective dose thresholds, only 1.1% of laboratories
employed a dose #9 mSv in any given patient,
whereas 9.8% had a dose >20 mSv (Figure 2). More-
over, nearly 1 in 11 cases used the rest Tl201/stress
Tc99m dual isotope protocol.
Figure 3 plots the median (interquartile range)
average effective doses for rest and stress MPI for all
submitting laboratories and for the normal MPI case.
For those with a normal MPI, use of the stress-only
FIGURE 1 Cumulative Distribution of Patient-Speciﬁc Median Effective Dose Across
IAC Participating Laboratories (N ¼ 1,074)
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The cumulative plot of myocardial perfusion imaging effective doses demonstrates that
only 1.5% of laboratories reported a median dose #9 mSv while 9.6% of laboratories
reported a median dose of >20 mSv. The majority of laboratories reported a median
effective dose between 10.1 and 20.0 mSv. IAC ¼ Intersocietal Accreditation Commission.
FIGURE 2 Proportion of Cases Across 1,074 Participating Laboratories With an
Effective Dose #9 and >20 mSv as Well as the Percentage Using Dual Isotope MPI
0.0%
5.0%
10.0%
15.0%
20.0%
≤ 9 mSv
1.1%
> 20 mSv
9.8%
Dual Isotope
8.7%
This ﬁgure illustrates the patient-speciﬁc cases by dose or protocol categories whereas
Figure 1 plots median laboratory dose. MPI ¼ myocardial perfusion imaging.
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1173protocol could reduce the average effective dose by
nearly 25%.
COMPARISON OF OBSERVED TO RECOMMENDED
AVERAGE RADIATION EXPOSURE. The average
observed exposure for each protocol was compared
with the average guideline-directed dosing recom-
mendation from ASNC (13). Although there was a
strong correlation (r ¼ 0.93) between observed and
recommended exposure, the guideline-directed rec-
ommended exposure was signiﬁcantly lower (mean
difference: 0.9  2.09, p < 0.0001), supporting
opportunities for optimized dose-reduction practices
across participating laboratories. Compared with
the guideline-directed recommended dose, labora-
tories administered a higher effective dose for
dual isotope and 1-day Tc99m protocols, þ3.3 mSV
and þ0.9 mSv (13).
Our model simulation results revealed that
replacement of a rest Tl201/stress Tc99m dual isotope
protocol with the average guideline-directed recom-
mended Tc99m 1-day protocol dose would yield a size-
able reduction in overall population radiation
exposure. Based on this simulation, the guideline-
directed average effective dose for a laboratory
would be reduced to 13.4 mSv, with only 2.6% of doses
being >20 mSv (p < 0.0001). From this model, an ex-
amination of radiation effective doses reveals that
maximum exposure would be reduced from 42.4 mSv
to 33.4 mSv (p < 0.0001).
TEMPORAL CHANGES IN RADIATION DOSIMETRY.
Additional analyses compared temporal changes in
radiation dosimetry from 2012 to 2013 (Table 3). We
failed to observe any signiﬁcant differences in the
average effective doses over time (2012: 15.1  5.7
mSv and 2013: 14.7  5.1 mSv, p ¼ 0.19). The per-
centage of exposures #9 mSv was 1.1% in 2012 and
2013 (p ¼ 0.92). Additionally, there was no statistical
difference in the frequency of effective doses >20
mSv, with 10.6% occurring in 2012 and 8.4% in 2013
(p ¼ 0.22). However, we did observe a trend in
reduced use of dual isotope imaging: from 10.1% in
2012 to 6.9% in 2013 (p ¼ 0.04). Of the sustained users
of dual isotope imaging, no difference in average ra-
diation effective dose was observed from 2012
to 2013.
DISCUSSION
During the past decade, we have observed an
increased rigor in evaluation of the appropriate use
and justiﬁcation of exposure to ionizing radiation for
cardiovascular imaging procedures such as MPI and
cardiovascular computed tomographic imaging (4).
Concomitant to this are increasing requirements forMPI laboratories to be accredited in order to qualify
for reimbursement from both public and private
payers. The IAC data repository provides a unique
opportunity to assess “real-world” MPI practice and
radiation dosing patterns in the United States. Ob-
servations from the IAC data repository may provide a
unique means to propose data-driven standards for
MPI and other imaging modality practices and to
track proposed performance standards of high-
quality imaging practices in the United States. The
current report includes a nationwide sample of 5,216
FIGURE 3 Median (IQR) Average Effective Doses for Rest þ Stress MPI
sesaCIPMlamroNsesaCIPMlatoT
Stress Only = 24.6% Potential
Reduction in Total Effective Dose
0.0
2.0
4.0
6.0
8.0
10.0
12.0
M
ed
ia
n 
Ef
fe
ct
iv
e 
D
os
e 
(25
, 
75
 
pe
rc
en
til
e)
Rest Stress Rest Stress
The overall rest and stress effective doses for all 1,074 laboratories are reported along with
the rest and stress MPI effective doses for the normal MPI cases. This ﬁgure illustrates the
potential for effective dose reduction with use of stress-only imaging. IQR ¼ interquartile
range; MPI ¼ myocardial perfusion imaging.
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1174patients with 10,405 administered rest and stress MPI
radiopharmaceutical doses evaluated from 1,074
laboratories.
CURRENT LABORATORY EFFECTIVE DOSE FOR
MPI. Few previous reports, largely using self-
reported data, have been published revealing cur-
rent MPI protocol use (4). As reported in a 2001 ASNC
survey, dual isotope MPI use was reported in 72% of
patients (14). By comparison, in a recent report from
2011, Einstein et al. (4) reported from an ASNC
member survey (with a response rate of w20%) that
dual isotope MPI was used in 15.6% of laboratories.
Our study demonstrated further decline in dual
isotope MPI use from 10.1% in 2012 to 6.9% of patients
in 2013. This represents a positive trend toward re-
ductions in high exposures, but additional ﬁndingsTABLE 3 Comparing Mean Radiation Effective Dose (in mSv) by
Protocol From 2012 to 2013
2012 2013 2012 2013 p Value
1-day 2,446 1,876 12.9  1.7 12.9  1.9 0.502
2-day 224 166 17.8  2.9 18.1  3.0 0.286
Dual isotope 256 137 32.9  3.6 32.6  3.4 0.346
Tl201 46 42 24.3  3.1 23.5  2.8 0.198
Stress-only 15 8 8.01  1.8 6.4  3.2 0.142
Values are n or mean  SD.
Tl201 ¼ thallium Tl 201.from our IAC registry also support that further re-
ductions (i.e., to 2.9%) may be realized. From a sur-
vey of MPI laboratories in Germany, a notable
decrease in the use of Tl201 was observed from 2005 to
2012 (20% to 5%) (15).
ACHIEVING POPULATION DOSE-REDUCTION STRATEGIES.
Our results from unselected laboratories revealed an
average effective dose of 14.9 mSv. From a recent
2012 survey in Germany (15), the average effective
dose per patient was estimated at 7.4 mSv. The lower
German radiation doses may reﬂect tighter control
based on the regulations of the German Ofﬁce for
Radiation Protection that were initiated in 2003. It
remains plausible that additional U.S. regulations,
particularly in the form of a diagnostic reference
levels applied as performance metrics may be helpful
to further reduce unnecessarily high effective dose
utilization practices (4).
In 2010, ASNC proposed radiation dose-reduction
recommendations targeting a total effective dose
of #9 mSv for a minimum of 50% of MPI patients
tested in a given laboratory by 2014 (7). Our results
reveal that this goal has not been achieved; only 1.9%
of all studies were #9 mSv, and only 1.4% laboratories
administered #9 mSv in >50% of cases. Hindsight
reveals that although laudable, this goal of #9 mSv
was largely unrealistic, based on the IAC data re-
pository ﬁndings. The current age of MPI equipment,
lack of physician and technologist’s knowledge of
contemporary dose-reduction practices, or the failure
of positron emission tomography to be optimally used
in the United States are all factors contributing to a
failure to achieve this laboratory goal of #9 mSv for
50% of patients (7–14). As widespread laboratory
dosing practices were not available when this tar-
geted level of #9 mSv was devised, the use of the IAC
data repositories and other databases may prove
optimal to set realistic quality-based standards for
radiation dose practices as well as other metrics, such
as appropriate use criteria (16).
A recent National Institutes of Health–sponsored
symposium recently made strict recommendations
for limiting and tracking radiation effective doses of
>20 mSv to a minimal number of patients with
justiﬁed indications for MPI (5). This target was
obviously focused on high-dose exposure, such as
with dual isotope MPI and adoption of this recom-
mendation, based on IAC data, could have a signiﬁ-
cant effect in lowering overall radiation exposure for
w1 in 10 patients. As the average radiation exposure
for laboratories using the dual isotope protocol was
32.8 mSv, adoption of a 20-mSv threshold would
encourage laboratories to eliminate use of the dual
isotope protocol and reduce exposures for the
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 1 0 , 2 0 1 5 Jerome et al.
O C T O B E R 2 0 1 5 : 1 1 7 0 – 6 Adherence to Radiation Reduction Recommendations for MPI
1175majority of patients now receiving high effective
doses in the IAC data repository.
REDUCING POPULATION EXPOSURE BY TARGETING
HIGH EFFECTIVE DOSE CASES. Importantly, the
dual isotope protocol has the highest potential to
affect projected cancer risk for patients undergoing
MPI (5,7). Recent estimates reported that the use of
dual isotope MPI can be expected to result in 25
(range 9 to 58) incident cancer cases for every 10,000
tested patients, a rate 2.5-fold higher than that of a
1-day Tc99m protocol (incident cancer cases: 10 per
10,000 tested patients) (8).
Elimination of the dual isotope protocol with sub-
stitution of a Tc99m 1-day protocol would result in a
signiﬁcant decrease in radiation exposure, based on
our ﬁndings. The IAC data repository of 1,074 labo-
ratories represents a total volume of nearly 1.5 million
MPI studies performed each year. Replacing the dual
isotope protocol with the Tc99m 1-day protocol would
lower the radiation exposure byw2-fold and improve
the safety of more than 100,000 patients undergoing
MPI each year in the United States.
In a previous National Institutes of Health–
sponsored symposium, the diagnostic reference level
for tracking was proposed at >20 mSv (5). We
observed that w10% of patients received an effective
dose >20.0 mSv, which, based on our modeling, could
be reduced to a sizeable extent and improve overall
population exposure appreciably. It would seem
reasonable that use of the IAC repository may be a
means of tracking radiation effective doses and to
document adherence to the use of high-dose expo-
sures (i.e., >20 mSv) as part of the accreditation
process. As many physicians are relying on databases,
such as the IAC repository, for documentation of their
performance improvement activities for their main-
tenance of certiﬁcation, the development of a more
rigorous educational program and tracking of labo-
ratory radiation exposures may prove an optimal
means to reduce patient effective doses.
STRESS-ONLY MPI PROTOCOL USE. Stress-only MPI
remains a valuable means to signiﬁcantly reduce total
radiation exposure (17–20). By applying stress-only
imaging, the stress image is performed ﬁrst and if
normal, then the rest dose is not required. Unfortu-
nately, the IAC data repository revealed a very low
use of the stress-only protocol (1.4%). Considering
data only from 2-day protocols (average radiation
exposure of 8.8 mSv for the ﬁrst dose and 8.9 mSv for
the second dose), if stress imaging was performed
ﬁrst and the second (rest) dose was eliminated in
patients with a normal study, patients would realize a
sizeable reduction in radiation exposure (w25%).STUDY LIMITATIONS. Important limitations should
be discussed with regard to our current ﬁndings.
First, we applied a large, nationwide data repository
whose primary use is for accreditation. The submitted
cases were for review of image quality and interpre-
tive acumen and not for consideration of radiation
dose practices. As such, some referral and selection
bias may be operational, although our data reﬂect a
broader representation of MPI laboratories than pre-
vious survey reports have (4). There was no mecha-
nism to determine whether the protocol intent
started as stress-only but rest images were subse-
quently acquired because the stress study was
abnormal. We moreover did not include cardiac
positron emission tomography MPI, which has lower
radiation exposure. A further limitation is that the
administered dose was extracted from the patient
report and may not reﬂect the true amount of
administered radioactivity. In addition, at the time of
data collection, some patient characteristics such as
height and weight were not mandatory reporting re-
quirements and thus were not available. The IAC
reporting requirements have been revised to require
the addition of patient height, weight, and sex
beginning 2016. The study is also limited in that ra-
diation exposure for both Tc99m sestamibi and Tc99m
tetrofosmin was assumed similar at 0.3 mSv/mCi,
although small differences do exist and radiation
dosimetry varies based on patient weight and sex.
Finally, this study only evaluated laboratories
applying for IAC accreditation, which represents a
large percentage of outpatient laboratories, and the
results may not be generalizable to other populations.
CONCLUSIONS
The results of our study suggest that strategies to
lower radiation exposure such as stress-only imaging
are underused. Use of the data repositories, such as
the IAC, may prove an optimal means to incentivize
physicians for performance improvement and to
document radiation dose-reduction practices. Find-
ings from our analyses reveal that there are signiﬁ-
cant opportunities for reducing radiation exposure in
the United States, and increased educational efforts
or proscriptive dosing regimens may be required for
laboratories to optimally lower radiation exposure for
the large sector of stable ischemic heart disease pa-
tients undergoing MPI each year.
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PERSPECTIVES
COMPETENCY IN PRACTICE-BASED LEARNING:
Although radiation dose-reduction recommendations
have been available since 2010, this study supports that
current strategies to lower radiation exposure are un-
derused across a wide spectrum of nuclear cardiology
laboratories. A combination of radiation dose-reduction
techniques such as stress-only imaging, elimination of
dual isotope imaging, or weight-based dosing should be
evaluated and incorporated into daily practice to opti-
mize image quality at the lowest possible radiation
dose. More rigorous incorporation of performance
measures and dose reference levels into accreditation
and patient registries are an important means to
improve the safety of populations at risk for coronary
artery disease.
TRANSLATIONAL OUTLOOK: Additional comprehen-
sive studies that evaluate radiation exposure with image
quality and study appropriateness are needed. In addi-
tion, the inclusion of individual patient characteristics
such as sex, age, height, and weight should be evaluated
along with the accuracy of imaging.
Jerome et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 1 0 , 2 0 1 5
Adherence to Radiation Reduction Recommendations for MPI O C T O B E R 2 0 1 5 : 1 1 7 0 – 6
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